FDA Person
FDAPhilip F. Istafanos
View detailed information about Philip F. Istafanos, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 15 inspections of 15 companies, 2016–2026.
Inspections (15)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| August 11, 2026 | Alcami Carolinas Corporation | Not classified | Drug Quality Assurance | #1330734 |
| February 27, 2025 | ABC Pharmaceuticals | VAI | Drug Quality Assurance | #1262486 |
| June 14, 2024 | Jubilant HollisterStier General Partnership | OAI | Monitoring of Marketed Animal Drugs, Feed, and Devices | #1242347 |
| April 19, 2024 | Genentech, Inc. | VAI | Drug Quality Assurance | #1235654 |
| January 26, 2024 | Specialty Process Labs LLC | OAI | Drug Quality Assurance | #1230275 |
| June 18, 2019 | Pharmascience Inc. | VAI | Drug Quality Assurance | #1093861 |
| June 7, 2019 | PF Soins de Sante SRI | VAI | Drug Quality Assurance | #1092301 |
| May 31, 2019 | Pacifico National, Inc. dba AmEx Pharmacy | VAI | Drug Quality Assurance | #1091321 |
| March 22, 2019 | Icrom Spa | Not classified | #1085563 | |
| March 15, 2019 | Actavis Italy Spa A Socio Unico | VAI | New Drug Evaluation | #1083251 |
| February 12, 2019 | Amphastar Pharmaceuticals, Inc. | VAI | Generic Drug Evaluation | #1079028 |
| March 16, 2018 | Aurobindo Pharma Limited | VAI | Drug Quality Assurance | #1046218 |
| October 10, 2017 | Pharmaceutical Laboratories and Consultants, Inc. | OAI | Drug Quality Assurance | #1028257 |
| September 8, 2017 | Pentec Health | NAI | Drug Quality Assurance | #1030994 |
| December 22, 2016 | Magellan Rx Pharmacy, LLC | OAI | Drug Quality Assurance | #996515 |
Documents (11)
- 483 · Pacifico National, Inc. dba AmEx Pharmacy · May 31, 2019
- 483 · Revance Therapeutics, Inc. · February 27, 2025
- 483 · Catalent Pharma Solutions LLC · December 15, 2022
- 483 · Panacea Biotec Pharma Limited · February 20, 2020
- 483 · ABC Pharmaceuticals · February 27, 2025
- 483 · Sun Pharmaceutical Industries Limited · February 7, 2020
- 483 · Icrom Spa · March 18, 2019
- 483 · Actavis Italy Spa A Socio Unico · March 15, 2019
- 483 · Samchundang Pharm Co., Ltd. · October 25, 2019
- 483 · Specialty Process Labs LLC · January 26, 2024
- 483 · Jubilant HollisterStier General Partnership · June 14, 2024
Frequently inspected with (10)
Mindy M. Chou
3 shared
Marcus A. Ray
Supervisory Consumer Safety Officer, China Office
2 shared
Alice S. Tsao
Consumer Safety Officer at FDA
1 shared
Ashar P. Parikh
1 shared
Brandon C. Heitmeier
1 shared
Christina A. Miller
Senior Compliance Manager
1 shared
Claire O. Nicholls
1 shared
Clifton L. Randell
Microbiologist
1 shared
Crystal Monroy
1 shared
Debra I. Love
Investigator
1 shared
Person Information
Name
Philip F. Istafanos
Role
ISSUING OFFICER
ID: c2fcfe52-1070-4551-bffc-f8bcfad5b30b
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.